These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12871546)

  • 1. Complete and sustained phenotypic correction of hemophilia B in mice following hepatic gene transfer of a high-expressing human factor IX plasmid.
    Ye X; Loeb KR; Stafford DW; Thompson AR; Miao CH
    J Thromb Haemost; 2003 Jan; 1(1):103-11. PubMed ID: 12871546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo.
    Miao CH; Thompson AR; Loeb K; Ye X
    Mol Ther; 2001 Jun; 3(6):947-57. PubMed ID: 11407909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Human coagulation factor IX gene therapy in murine hemophilia B by hydrodynamic delivery and site-specific genomic integration].
    Zhang L; Gu DS; DU WT; Liu PX; Lu SH; Yang RC
    Zhonghua Xue Ye Xue Za Zhi; 2010 May; 31(5):294-9. PubMed ID: 21122306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer.
    Cohn EF; Zhuo J; Kelly ME; Chao HJ
    J Thromb Haemost; 2007 Jun; 5(6):1227-36. PubMed ID: 17362228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term phenotypic correction in factor IX knockout mice by using ΦC31 integrase-mediated gene therapy.
    Keravala A; Chavez CL; Hu G; Woodard LE; Monahan PE; Calos MP
    Gene Ther; 2011 Aug; 18(8):842-8. PubMed ID: 21412285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preparation of rAAV2/hFIX and experimentally application to gene therapy for hemophilia B].
    Peng JQ; Dong XY; Peng M; Chen L; Tan SP; Yuan H; Chen FP; Xue JL; Wu XB
    Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):513-8. PubMed ID: 15569526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for hemophilia B with liver-specific element mediated by Rep-RBE site-specific integration system.
    Xu Z; Ye J; Zhang A; Xie L; Shen Q; Xue J; Chen J
    J Cardiovasc Pharmacol; 2015 Feb; 65(2):153-9. PubMed ID: 25295466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulating immunogenicity of factor IX by fusion to an immunoglobulin Fc domain: a study using a hemophilia B mouse model.
    Levin D; Lagassé HA; Burch E; Strome S; Tan S; Jiang H; Sauna ZE; Golding B
    J Thromb Haemost; 2017 Apr; 15(4):721-734. PubMed ID: 28166609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients.
    Qiu X; Lu D; Zhou J; Wang J; Yang J; Meng P; Hsueh JL
    Chin Med J (Engl); 1996 Nov; 109(11):832-9. PubMed ID: 9275366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs.
    Kay MA; Rothenberg S; Landen CN; Bellinger DA; Leland F; Toman C; Finegold M; Thompson AR; Read MS; Brinkhous KM
    Science; 1993 Oct; 262(5130):117-9. PubMed ID: 8211118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulated human primary myoblasts deliver functional hFIX in hemophilic mice.
    Wen J; Xu N; Li A; Bourgeois J; Ofosu FA; Hortelano G
    J Gene Med; 2007 Nov; 9(11):1002-10. PubMed ID: 17868187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creation of a mouse expressing defective human factor IX.
    Jin DY; Zhang TP; Gui T; Stafford DW; Monahan PE
    Blood; 2004 Sep; 104(6):1733-9. PubMed ID: 15178576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential limits of AAV-based gene therapy with the use of new transgenes expressing factor IX fusion proteins.
    Le Quellec S; Dane A; Enjolras N; McIntosh J; Rosales C; Negrier C; Nathwani A
    Haemophilia; 2019 Jan; 25(1):e11-e18. PubMed ID: 30520547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained delivery of therapeutic concentrations of human clotting factor IX--a comparison of adenoviral and AAV vectors administered in utero.
    Schneider H; Mühle C; Douar AM; Waddington S; Jiang QJ; von der Mark K; Coutelle C; Rascher W
    J Gene Med; 2002; 4(1):46-53. PubMed ID: 11828387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Adeno-Associated Viral Vectors Expressing Human Coagulation FIX-E456H Variant in Hemophilia B Mice.
    Le Quellec S; Dane AP; Barbon E; Bordet JC; Mingozzi F; Dargaud Y; Marais T; Biferi MG; Négrier C; Nathawani AC; Enjolras N
    Thromb Haemost; 2019 Dec; 119(12):1956-1967. PubMed ID: 31659733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for hemophilia B mice with scAAV8-LP1-hFIX.
    Lu W; Zhou Q; Yang H; Wang H; Gu Y; Shen Q; Xue J; Dong X; Chen J
    Front Med; 2016 Jun; 10(2):212-8. PubMed ID: 27052253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new potent hFIX plasmid for hemophilia B gene therapy.
    Lee JS; Lee M; Kim SW
    Pharm Res; 2004 Jul; 21(7):1229-32. PubMed ID: 15290864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro.
    Miao CH; Ohashi K; Patijn GA; Meuse L; Ye X; Thompson AR; Kay MA
    Mol Ther; 2000 Jun; 1(6):522-32. PubMed ID: 10933977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balloon catheter delivery of helper-dependent adenoviral vector results in sustained, therapeutic hFIX expression in rhesus macaques.
    Brunetti-Pierri N; Liou A; Patel P; Palmer D; Grove N; Finegold M; Piccolo P; Donnachie E; Rice K; Beaudet A; Mullins C; Ng P
    Mol Ther; 2012 Oct; 20(10):1863-70. PubMed ID: 22828499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Clinical Candidate AAV3 Vector for Gene Therapy of Hemophilia B.
    Brown HC; Doering CB; Herzog RW; Ling C; Markusic DM; Spencer HT; Srivastava A; Srivastava A
    Hum Gene Ther; 2020 Oct; 31(19-20):1114-1123. PubMed ID: 32657150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.